Lucile Adams-Campbell

Prosperdtx Launches Strategic Collaboration With Health Equity Researchers and Seqster to Improve Health Equity for Cancer Patients

Retrieved on: 
Wednesday, May 18, 2022

Our collaboration with Seqster will enable us to demonstrate how Prosperdtxs digital health platform can help cancer patients live better lives with improved and cost-effective health outcomes.

Key Points: 
  • Our collaboration with Seqster will enable us to demonstrate how Prosperdtxs digital health platform can help cancer patients live better lives with improved and cost-effective health outcomes.
  • Seqsters Operating System will enable Prosperdtx to deliver precision cancer care to cancer patients in real-time, said Joseph Swiader, co-founder and CEO of Prosperdtx.
  • Prosperdtx is maximizing the continuity of cancer care so that patients can live longer, better lives while reducing the cost of healthcare.
  • Seqster has nationwide coverage of EHRs from hospitals and medical groups, genomic DNA, wearables, pharmacy, and social determinants of health data.